Zhao, M., Zhang, Y., Li, J., Li, X., Cheng, N., Wang, Q., . . . Zhou, C. (2018). Histone deacetylation, as opposed to promoter methylation, results in epigenetic BIM silencing and resistance to EGFR TKI in NSCLC. Oncol Lett.
Dyfyniad Arddull ChicagoZhao, Mingchuan, et al. "Histone Deacetylation, As Opposed to Promoter Methylation, Results in Epigenetic BIM Silencing and Resistance to EGFR TKI in NSCLC." Oncol Lett 2018.
Dyfyniad MLAZhao, Mingchuan, et al. "Histone Deacetylation, As Opposed to Promoter Methylation, Results in Epigenetic BIM Silencing and Resistance to EGFR TKI in NSCLC." Oncol Lett 2018.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.